A Study on analysis of validity of urinary calcium and creatinine ratio as a screening test for pre-eclampsia by Udaya Aruna, S
A STUDY ON ANALYSIS OF VALIDITY OF URINARY CALCIUM AND 
CREATININE RATIO AS A SCREENING TEST FOR PRE-ECLAMPSIA
Dissertation Submitted to
THE TAMIL NADU DR. M. G. R. MEDICAL UNIVERSITY
In partial fulfilment of the regulations 
for the award of the degree of
M. D.   (BRANCH   - II)
OBSTETRICS & GYNAECOLOGY
R.S.R.M. LYING IN HOSPITAL 
STANLEY MEDICAL COLLEGE 
THE TAMIL NADU DR. M. G. R. MEDICAL UNIVERSITY
CHENNAI, INDIA.
MARCH 2010
CERTIFICATE
This is to certify that the dissertation titled “A STUDY ON ANALYSIS OF VALIDITY OF URINARY 
CALCIUM AND CREATININE RATIO AS A SCREENING TEST FOR PRE-ECLAMPSIA” submitted 
by 
Dr.S. Udaya Aruna to the Faculty of Obstetrics and Gynaecology, The Tamilnadu Dr. M.G.R. Medical 
university, Chennai in partial fulfillment of the requirement for the award of M.D. Degree (Obstetrics 
and Gynaecology) is a bonafide research work carried out by her under our direct supervision and 
guidance.
DEAN, 
Stanley Medical College,
Chennai - 1.
Dr. C. VENI 
M.D., D.G.O., Dip. NB 
Superintendent,
Professor & HOD,
R.S.R.M. Lying in Hospital,
Stanley Medical College,  Chennai - 1.
CONTENTS
S.NO TITLE PAGE NO
ACKNOWLEDGEMENT
1. INTRODUCTION 1
2. REVIEW OF LITERATURE 4
3. AIM OF THE STUDY 47
4. MATERIALS AND METHODS 48
5. RESULTS & ANALYSIS 54
6. DISCUSSION 64
7. SUMMARY 74
8. CONCLUSION 75
9. PROFORMA
10. ABBREVIATION
11. BIBLIOGRAPHY
12. MASTER CHART
ACKNOWLEDGEMENT
I am extremely grateful to Dr.A.Priya M.S., D.O., Dean, Govt. Stanley Medical College 
Hospital and Dr.S.Chithra, M.D., Ph.D., Dean, Govt. Stanley Medical College for granting 
me permission to utilize the facilities of the Institute for my study.
I owe my deep sense of gratitude to Dr.C.Veni, M.D., D.G.O., Dip. NB., Superintendent,  
Govt. R.S.R.M Lying in Hospital, who not only permitted me to do the study but also whose 
encouragement and guidance helped me to complete the dissertation.
I am greatly indebted to Dr.A.Kalaichelvi, M.D., D.G.O., Dip NB. for her valuable guidance 
and constant support and gave much of her valuable time providing suggestions without 
which my dissertation would have been incomplete.
I express my sincere thanks to Prof.Dr.Amrita Pricilla Nalini, M.D., D.G.O., Prof. Dr.Hephzibah 
Kirubamani, M.D., D.G.O., Ph.D., Prof.Dr.T.Ruckmani, M.D., D.G.O., Department of  
Obstetrics and Gynaecology, R.S.R.M Lying Hospital for their guidance and encouragement 
and constant support to undertake my study.
I sincerely thank Prof.Dr.R.Lalitha, M.D., Head of the Department and Dr.K.Pramila, M.D., 
Associate Professor, Department of Biochemistry, SMC, Chennai for their help in fulfillment 
of this dissertation work and for their kind support and guidance.
My deep gratitude goes to Dr.R.Shanthi, M.D., Assistant Professor of Biochemistry for her  
valuable assistance in many ways and her stimulating suggestion and unfailing interest can 
never be adequately acknowledged.
I wish to thank all the Assistant Professors and my colleagues who encouraged me to 
undertake this study and for their kind support. 
I take immense pleasure in acknowledging all the mothers who gave their consent and co-
operated with me in this study.
And most of all I expresses my gratitude to my family and my friends who helped me all the 
way through.  
INTRODUCTION
INTRODUCTION
Pregnancy usually induces happiness but at times can also induce hypertension. Hypertensive disorders 
represent the most common medical complication of pregnancy. It complicates up to 7-10% of 
pregnancies of which pre-eclampsia / Eclampsia constitutes 70%, and Chronic hypertension 30%. Pre-
eclampsia has been recognized as pathological entity since the time of Hippocrates and ancient Greeks.
Pre-eclampsia complicates approximately 5 - 8% of pregnancies and is a major cause of maternal and 
perinatal morbidity (SIBAI et al, 1997, 5-8% ACOG 2002).
Pre-eclampsia and Eclampsia contribute 12% of all maternal deaths in the developing countries (WHO 
1999).
It is said that pre-eclampsia, eclampsia contributes to death of a women every 3 minutes worldwide. 
Infants of women with severe Pregnancy induced hypertension has 5 fold increase in mortality compare 
to infants of normotensive women.
Pre-eclampsia is a multiorgan disorder, and usually recognized by new onset of hypertension and 
proteinuria appearing in the second half of pregnancy.
Hypertensive disorders complicating pregnancy represent one facet of a complex disease process. 
Gestational hypertension, pre-eclampsia, eclampsia majority of these conditions are preventable.
This has led to the interest in screening. Screening the deliberate examination of substantial segments 
of the population in search for disease at its earlier stages, is a logical extension of the role of 
preventive medicine. If we wish to prevent such disorder we must seek ways of preventing (or) 
ameliorating the disease process. In preventing  this disorder the most important factor is lack of timely 
prediction.
Several methods have been proposed to identify the pregnant women who are at risk for pre-eclampsia. 
Renal function changes in pre-eclampsia which has been documented and several prospective studies 
indicate that atleast some of the changes are present before the clinical diagnosis of pre-eclampsia. One 
such change is the association of hypocalciuria with pre-eclampsia as early as 24 weeks.
The purpose of this study is to predict the development of pre-eclampsia in symptom free pregnant 
women using urinary calcium/ creatinine ratio (UCCR), For a screening test to be of value, it should be 
selective, reliably cheap and easy to perform. It should increase the predictive value and the 
prophylactic measures must be effective. 
Good antenatal supervision followed by appropriate treatment will definitely help mother and baby for 
good outcome.
REVIEW OF LITERATURE
Pregnancy can induce hypertension in normotensive women (or) aggravate already existing 
hypertension. Hypertensive disorder in pregnancy continues to take heavy toll of maternal and fetal 
lives.
Pre-eclampsia, eclampsia remains a difficult puzzle to solve, and it is still in a cloud of mystery.
HISTORICAL PERSPECTIVE OF PRE - ECLAMPSIA 
Zweiff first termed pre-eclampsia as “Toxemia” 
Zweiff & Chesley called it is disease of theories probably, the oldest reference is the Athvaida - 
Veda 200 BC.
Fishberg (1899) - Pre-eclampsia as a cause of essential hypertension.
Lever And Simpson 1843 - Discovery of proteinuria in pre eclampsia.
Lahlein 1918, Fahr 1920 - Significant changes in the glomeruli.
Farguhar 1959 - demonstrated glomerular capillary endotheliosis by electron microcopy.
INCIDENCE
Incidence of pre-eclampsia in commonly cited to be about 5%. Incidence is influenced by parity, race 
and genetic factors. (Women with positive family history of pre-eclampsia in her mother or in her 
sister).
In India the incidence of pre-eclampsia amongst hospital patients is about 7-10% of all antenatal 
admission. In United Kingdom, the incidence is 10%. In USA it is 6-7%. The incidence is found to be 
higher among nulliparous women, age less than 20 years and more than 35 years.
DEFINITION
Gestational hypertension or Transient Hypertension, previously called as Pregnancy Induced 
Hypertension.
A diastolic BP of 90mmHg (or) higher (or) a systolic BP level of 140mm Hg or higher for the first time 
during pregnancy after 20 weeks of gestation in a women with previously normal blood pressure but in 
whom proteinuria is not developed (NHBPEP 2000; ACOG 2002).
PRE-ECLAMPSIA 
Pre-eclampsia is a pregnancy specific syndrome of reduced organ perfusion secondary to vasospasm 
and endothelial activation.
INTERNATIONAL SOCIETY FOR STUDY OF HYPERTENSION IN PREGNANCY 
(Davey and MacGillivray 1988) (ISSHP)
1. One measurement of Diastolic BP equal (or) >110mm Hg
2. Two consecutive measurement of diastolic BP=/>90mm Hg, 4 (or) more hours apart.
3. Korotkoff’s V sound is to be measured for measuring diastolic component.
A Diastolic Blood Pressure of 90mm Hg after 20 weeks of pregnancy is usually considered the 
threshold for diagnosis. A diastolic pressure of 90mmHg is 3SD greater than mean for mid pregnancy 
and 2SD above the mean for 34 weeks gestation. 1.5 SD above mean at term, reflecting the 
physiological increase in blood pressure towards term (MACGILLIVRAY et al, 1969).
BLOOD PRESSURE MEASUREMENTS
1. Conventional mercury sphygmomanometer - Gold standard for blood pressure 
measurement.
2. Use of bell of stethescope as it better amplifies the Korotkoff (K) Sound.
3. Cuff size should be adequate. Bladder length 80% of arm circumference, and width 
should be 40% of arm circumference.
4. Patient should be in sitting posture with her right arm well supported in a horizontal 
position at the level of heart and her feet supported (Sibbai).
5. Inflate the cuff above the systolic pressure as recognized by disappearance of the radial 
pulse.
6. Use of Korotkoff (V) (disappearance of sound) to determine diastolic blood pressure.
CLASSIFICATION
NATIONAL HIGH BLOOD PRESSURE EDUCATION PROGRAMME WORKING 
GROUP (2000) (NHBPEP)
I. Gestational Hypertension
Gestational Hypertension or transient Hypertension, Previously called as Pregnancy Induced 
Hypertension.
 > 140/90 mmHg of BP for the first time in pregnancy.
 No proteinuria
 Blood pressure returns to normal < 12 weeks postpartum
 Final diagnosis made only postpartum.
II. Pre Eclampsia
Occurrence of Hypertension in combination with proteinuria developing after 20 weeks of gestation in 
a previously normotensive, non proteinuric pregnant women.
It is a pregnancy specific syndrome of reduced organ perfusion secondary to vasospasm and endothelial 
activation.
Minimum criteria Increased certainity of Pre eclampsia
 >  140/90 mm Hg >20 weeks of 
gestation
 Proteinuria > = 300mg/24 hrs (or) 
> = 1 + dipstick
 Blood Pressure > = 160/110mmHg
 Proteinuria 2g/24 hours (or) >=2+ 
dipstick
 Serum Creatinine 1.2mg/dl unless known 
to be previously elevated 
 Platelets <1,00,000/mm3
 Microangiopathic haemolysis
 Elevated ALT/ AST
 Persistent headache/ Other cerebral or 
visual disturbances
 Persistent epigastric pain.
III. Eclampsia
Seizure that cannot be attributed to other cause in a women with pre-eclampsia.
Superimposed Pre-eclampsia on Chronic Hypertension
New onset proteinuria > 300 mg/24 hours in hypertensive women but proteinuria before 20 weeks of 
gestation.
Chronic Hypertension
BP > 140/90 mmHg before pregnancy or diagnosed before 
20 weeks gestation not attributable to gestational trophoblastic disease.
Proteinuria
It is directly proportional to maternal and perinatal mortality, (Harth et al 2000) and morbidity.
It is an important sign of pre eclampsia (Chesley 1985). It reflects the glomerular damage that causes 
leakage of proteins through the basement membrane. 
Significant proteinuria is defined by 300mg/24 hours or persistent 30mg/dl (1+dipstick) in random 
clean catch sample on at least 2 occasions collected 6 hours apart. If proteinuria is >5gm/24 hours (or) 
persistent 3+ dip stkck (or) more the condition is called as severe pre eclampsia (ACOG Practice 
Bulletin No.33, January 2002).
Edema
Edema is no longer a part of current definition (or) as a diagnostic criteria of pre- eclampsia (Williams 
22nd Edition) and it is seen in nearly 80% of women in last few weeks (Robetson 1971).
Weight Gain
Excessive weight gain of >0.5kg/week because of extracellular fluid volume expansion.
THEORIES REGARDING CAUSATION OF PRE-
ECLAMPSIA
IMMUNOLOGICAL
The trophoblastic cells do not express the usual class-I & II MHC antigen, they express unique HLA-G 
enclosed class-I MHC molecule which allow the trophoblast cells to invade deep into spiral arteries. In 
patients developing pre-eclampsia there is immune resistance to the invading trophoblast by the 
maternal immune system, results in poor spiral artery remodeling which is a initially cited feature in 
pre-eclampsia (ZHOU 1977). Pre-eclampsia is immune mediated, certainly the microscopic changes at 
maternal placental interface are suggestive of acute graft rejection (Labarrere 1998).
The risk is enhanced when formation of blocking antibodies to antigenic sites in placenta is impaired 
(Bardegue and Asso, 1991) (or) where the number of antigenic sites is increased as in hyperplacentosis 
(Beer 1979).
 T helper cells were in a lower proportion in pre-eclampsia (Bardeguez and Associates). 
T-lympohcyte secrete cytokines that promote implantation and their dysfunction may 
favour pre-eclampsia (Hayashi & Associates 2004, Whitecar & Collegues 2001).
 Antibodies to B2 glycoprotein I is more relevant immune complex and antiendothelial 
antibodies may be involved (Taylor et al., 1999).
 Immunocytochemical analysis - VCAM, increased in Pre-eclampsia.
 The pre-eclampsia develops more frequently in multiparous women impregnated by a 
new Consort (Mostello & Conera 2002, Trapin and Colleagues 1996).
GENETIC SUSCEPTIBILITY
Hereditary estimate of 31% of pre-eclampsia (Nilsson et al) 
1. Chesley and Cooper 1986, Pregnancy Induced Hypertension is inheritable both by 
single gene (Broughton Piplus 1999) and Multifactorial inheritance.
2 Modes
a) Simple recessive model with genes acting in the mother 
(gene on chromosome 1, 3, 9)
b) Dominant model with incomplete penetration
2. Kilpatric reported an association HLA DR4
The transmission from mother to daughter is through HLADR4
3. Angiotensinogen gene variant T235 - high incidence of PIH (Arngrimsson et al)
4. Dizon Townsend and colleagues found high incidence of factor V laden mutation 
polymorphism gene variant 202109
5. Epigenetic features (or) imprinting is also involved in the pathogenesis of pre-eclampsia 
susceptibility locus on chromosome 10q 22-1. (Dudejans et al).
6. Hyperhomocystinaemia associated with methyltetrahydrofolate   (6778) Homozygozity 
(Coffer et al).
7. Polymorphism of TNF α and Gene - Mediating endothelial dysfunction, Lymphotoxins, 
IL1.
8. The eNOS gene susceptibility occurs in the region of chromosome 7q 36.
ENDOTHELIAL DYSFUNCTION
 Endothelial damage account for all aspects of pathophysiology of pre-eclampsia (Roberts  
et al 1998).
 Endothelial dysfunction results from “Generalised perturbation of normal maternal 
intravascular inflammatory adaptation to pregnancy (Redman and Colleagues (1999).
 Immunologically mediated deficiency in trophoblastic invasion of spiral arteries results 
in release of a number of factors into maternal circulation. These changes inturn provoke 
activation of vascular endothelium (Hayman and Asso., 2000, Ness and Roberts 2000,  
Walker 2000).  Damaged endothelium activates endothelial cells to promote coagulation 
and increases sensitivity to vasopressor agents.
 Reduction of unbound serum level of Angiogenic factors such as VEGF and PLGF due 
to upregulation of soluble fms like tyrosine kinase receptor (Maynard et al) and Serum 
level of sFlt1 is increased in pre-eclampsia leads to endothelial dysfunction (Luttun and 
Carmeliet 2003).
 Recent study - increased level of asymmetric dimethyl arginine at 23-25 in pregnant 
women who is at risk of 
pre-eclampsia (important in nitric oxide cyclic guanosine monophosphate pathway).
 Prostaglandin theory (Wang et al 1991): In pre-eclampsia, the balance is between PGI2 
& TXA2 (Prostocycline) (Thromboxane A2) is titled so TXA2 is found to increased 
(Walsh 1985).
ENDOTHELINS
They are polypeptides with potent vasoconstricting property, higher level of Endothelin I is found in pre-
eclampsia (Clark Schiff 1992).
NITRIC OXIDE
 Decreased in pre-eclampsia (Anumba Ford Am obsgyn 181: 14 (1999). This concept is 
disproved. Decreased endothelial nitric oxide synthase expression (Wang & Collagen 
2004). Increased production of Nitricoxide as a compensatory  mechanism (Benedetto & 
Asso., 2000). It is a consequence of hypertension, but not the cause (Morris and 
Colleagues 1996).
 Ionic calcium is crucial for synthesis of vasosubstances in the endothelium like PGI2 
and Nitricoxide. An alteration in the action of Nitricoxide may be related to inactivation 
by free radical superoxide (secondary to inflammatory process) (Lopez et al).
DIETARY DEFICIENCY
Role of  dietary deficiency in the pathogenesis of pre-eclampsia (Mac Gillivary et al) Calcium 
concentration low in extracellular fluid, amount of ionic calcium entering the cell was increased 
making smooth muscle more sensitive to excitability (Ganong 1979).
Serum calcium decrease in pre-eclampsia (Dawson, Kelly and Co-authors Biological Trace element 
research May 2009 - Page: 107-116). An inverse relationship was found to be associated to serum 
calcium and incidence of pre-eclampsia (Sanders Sarks, Appel J of HT Dec 1995).
Belzian and Collegeues (1998): They reported that after mid pregnancy dietary supplementation with 2 
grams of elemental calcium/day significantly reduces the Incidence of pre-eclampsia.
OXIDANTS AND ANTIOXIDANTS
A work by Hubal et al have confirmed that pre-eclampsia may have its origin in a disturbed oxidation 
mechanism. Increased free radical in Pre-eclampsia (Wisdom and Ass., 1991), free radical causes 
endothelial damage.
PLACENTAL PROTEINS
Corticotrophin releasing factor, HCG, Activin A & inhibin A are said to play a role in pathogenesis of 
Pregnancy induced hypertension.
 Decreased intravascular volume
 Decreased glomerular filtration rate
VASOSPASM
Showing physiological distension of spiral arteries in deciduas (left) 
and it absence in Pre eclampsia (right)
Vasopasm that characteristic of the disease (Volhard). Vasopasm causes endothelial damage and 
interendothelial cell leakage which results in subendothelial deposition of fibrin and platelets and hence 
uteroplacental insufficiency (Brunner & Gavras 1975).
PREDISPOSING FACTORS
AGE
Young primi <20 years of age and all patients >30years of age are said to have increased chance of pre-
eclampsia (Bobrowski & Bottoms 1995).
PARITY 
Primigravida are 15 times more affected than multigravida. The incidence among primigravida is 
11.9% and multiparity is 4.7%. The incidence is 24% in new paternity because of shorter period of 
sperm exposure proceeding conception. 
CPEP - Calcium for Pre-eclampsia Prevention study shows significant risk for development of pre-
eclampsia in Nulliparity, specially noted at index visit
1. Body Mass Index Odds ratio 3.22 or = 35kg/m2 Vs 19.8kg/m2
2. Systolic blood pressure odds ratio 2.66 for >or=120 Vs <101mmHg.
3. Diastolic blood pressure odds ratio 1.72 for > or = 61mmHg Vs 60mmHg.
SOCIO-ECONOMIC STATUS 
(BASRD and Colleagues 1969) incidence not different among socio economic classes.
FAMILY HISTORY
Inheritance is 3 times if present in 1st degree relatives. 
Chesley has reported an incidence of 26% in daughters and 8% in daughter in law. Mendelian 
recessive trait is more acceptable.
WEIGHT
Risk of pre-eclampsia is progressively increasing from 4.3% for women with body mass index less than 
19.8 Kg/m2 to 13.3% for those greater than (or) equal to 35 kg/m2.
OBESITY 
Adipocytes lead to the formation of cytokines especially TNFα - which exacerbates of underlying 
essential hypertension.
TWINS 
13 versus 5% due to superabundance of trophoblastic tissues (Simbai & Co-workers)
DIABETES MELLITUS - 30%
HYDATIFORM MOLE
Confined to large rapidly growing moles in which the incidence of pre-eclampsia is 70% (Page 1939).
HYDROPS FOETALIS
Pre-eclampsia is due to hyperplacentosis
DIETARY DEFICIENCY
Deficiency of calcium associated with increased incidence of pre-eclampsia.
CLIMATE
In cold weather - increased peripheral vasoconstriction.
Renal disease 20% of pre-eclampsia can occur
Thrombophilias - Uteroplacental thrombus is frequently seen in pre-eclampsia (Dekkar 2003).
RECURRENCE
25 - 50% women had recurrence in their subsequent pregnancies.
Pre-eclampsia : 45.5%
Eclampsia : 1.4 %
Abruption : 2.5%
HELLP syndrome: 3%
SMOKING
Significant reduction in level of HCG and Estradiol level due to direct effect on the placental function 
(Bernstein et al 1989). Smoking reduces the incidence of pre-eclampsia.
HIGH RISK FACTORS FOR PRE-ECLAMPSIA (ADAPTED FROM DUCKITT AND 
HARRINGTON 2005 AND DEKKAR ET AL 1995)
Maternal related factors
1. First pregnancy
2. Extremes of age
3. Pre-eclampsia in a previous pregnancy
4. > 10 years since previous pregnancy
5. >40 years of age
6. Body mass index > 35 at booking
7. Family h/o. Pre-eclampsia (Mother (or) sister)
8. Diastolic BP >80 mm Hg at booking 
9. Proteinuria at booking
10. Multiple pregnancy
11. Underlying medical condition.
12. Obesity
13. Thrombophilia
14. Auto immune disorders 
Paternity related factors
1. Primi paternity
2. Limited sperm exposure
i. Donor insemination
ii. Oocyte donation
3. Partner who fathered a pre-eclampsia pregnancy in another women.
Pregnancy associated factors
1. Multiple pregnancy
2. Hydropsfoetalis
3. Chromosomal anomalies 
a. Trisomy 13
b. Triploidy
4. Hydatiform mole
PATHOPHYSIOLOGY
PRIMARY LEVEL
The presence of fetus is not necessary for pre-eclampsia to occur. But a placenta is an absolute must. 
Uteroplacental circulation is unique, it lacks a micro circulation.
Two lesions that involve spiral arterioles, which are the end arteries supplying Intra vascular space 
(Redeman 1991).
i) Deficient placentation - In normal pregnancy - spiral artery remodeling by 
trophoblastic invasion between 8 and 15 weeks of gestation so as to transmit the 
expanded blood volume after 20 weeks of gestation. So failure of trophoblastic invasion 
results in failure of the vessels to dilate and responds to vasoconstrictor stimuli resulting 
in decreased choriodecidual blood flow (Dixon and Robertson et al).
ii) Acute atherosis (Robertson et al 1963, Laberrere C) it is a late pathological occurrence. 
Lipids accumulates first in myointimal cells and then in macrophages (Madzali & 
Colleagues, 2000).
The dual pathology of the spiral arteries explains reduced placental flow and desaturation of the 
intervillous space. These changes are consistent with the maternal signs of pre-eclampsia.
Oxidative stress
At present, the most popular theory is “Oxidative stress”.
Reduced placental perfusion where prooxidants dominate over the antioxidants results in formation of 
free radicals. Imbalance between free oxygen radical and scavengers is in favour of oxidative stress.
Oxidative stress leads to increased production of lipid peroxides, TXA2 and decreased level of 
prostacyclin (PGI2). This imbalance triggers endothelial dysfunction and its clinical manifestations.
Recently decreased expression of reducing system like thioredoxin and glutaredoxin in placenta in a 
pre-eclampsia patients have been documented. Greater accumulation of 4- hydroxyl - 2 non renal 
(HNE) modified renal proteins which are markes for lipid peroxidation in the placenta of pre-
eclampsia.
In pre-eclampsia, increased production of nitric oxide, as a compensatory process, this nitricoxide 
competes with superoxide dismutase and combine with super oxide which is formed by reduction of 
oxygen to form peroxynitrite which has got toxic effect.
SECONDARY
Results from maternal adaptation to Ischemic placenta.
CARDIOVASCULAR SYSTEM
1. Haemodynamic change
a. Increased arterial sensitivity to Angiotensin II
b. Increased peripheral resistance
c. Decreased cardiac output
d. Increased blood pressure
2. Blood volume
a. Hemoconcentration is a hall mark of eclampsia 
b. Reduced circulating blood volume in women homozygous for T235 angiotensin gene 
type associated with pre-eclampsia (Silver & Asso., 2001).
RENAL SYSTEM
1. Reduced uric acid clearance
2. Reduced glomerular function
3. Reduced renal blood flow
4. Intrinsic renal changes (Pritchard & Colleagues 1984)
5. Proteinuria (Naeye & Friedman 1979, Meyer & Colleagues 1994)
6. Glomerular endotheliosis (Spargo et al 1959)
Glomeruli were enlarged by about 20% (Sheehan 2001)
7. Immunofluorescent staining identified fibrinogen changes (Lichtig et al 1975)
8. Urinary sediment - reflects renal changes (Ledou et al)
9. Reduced urate clearance (Chesley and Williams 1945)
10. Hypocalciuria (Taufield et al 1987): Pre-eclampsia is associated with the diminished 
urinary excretion of calcium because of increased tubular reabsorption.
11. Hyperuricaemia (Pollate et al 1960)
COAGULATION SYSTEM
1. Intravascular coagulation (Baker and Lunningham)
2. Thrombocytopenia, Platelet aggregation is reduced (Baker and cunningham 1999). 
Lower the platelet count, higher the maternal and fetal morbidity and mortality (LEDUC 
1992)
3. Fragmentation Haemolysis (Sanchez Ramos and Colleagues 1994). Increased 
erythrocyte membrane fluidity in women with HELLP syndrome.
4. Anti thrombin III - reduced (Chang and Co-workers 1992)
5. Fibronectin - elevated (Bru baker and Colleagues 1992)
6. Increased fibrinopeptide A.
HEPATIC SYSTEM
1. Elevation of liver enzymes (Combes and Adams 1972)
2. Increased hepatic artery resistance in Doppler sonography (Ooster Hof and Co-workers 
1994)
3. HELLP syndrome - haemolysis, elevated liver enzymes & Low platelets.
ENDOCRINE SYSTEM
1. Atrial natriuretic peptide - increased in women with pre-eclampsia (Gallery and 
Lindheimer 1999)
2. Increased plasma level of renin angiotensin.
TERTIARY
The systemic upsets of pre-eclampsia can eventually progress to decompensation which presents as one 
of the possible causes.
Tertiary pathology of pre-eclampsia
 Eclampsia
 Cerebral haemorrhage
 Cerebral odema
 Pulmonary edema
 Adult respiratory distress syndrome
 Retinal detachment
 Laryngeal odema
 Dissiminated intravascular coagulation
 HELLP syndrome
 Renal cortical necrosis
 Hepatic rupture
CALCIUM
Calcium is the fifth most common element and most prevalent cation in the body. It makes up 1.2-2% 
of body weight. The total body calcium content is 1000 - 1500 grams, 99% of this incorporated in bone 
where it exist as carbonates and phosphates and rest is found in extra cellular fluid.
SERUM CALCIUM
Normal serum calcium level ranges from 9.0-10.5mg/dl (2.2-2.6 mmol/L). About 45% of total calcium 
is in ionized form. Albumin is a major protein in which non - diffusible calcium binds. Ionized calcium 
is the physiologically active form. A decrease in serum albumin of 1g/dl results in decrease of about 
0.8mg/d in total serum calcium. Calcium exist in ionized form in extracellular fluid and regulates 
action on kidney, intestine and bone.
ABSORPTION
Absorbed in jejunam and duodenum against electric and concentration gradient. Absorption increased 
in acidic medium. Absorption requires 1,25 dihydroxy cholecalciferol. Major portion of filtered 
calcium is reabosorbed by hormone dependent mechanism in proximal convoluted tubule. Calcium 
hemostatic mechanism resides in convulted tubule of kidney.
EXCRETION
Excreted in faeces, urine and sweat. 130 mg/day calcium is excreted through faeces, 2-4 mg/kg/day via 
urine, 15mg/day of calcium is excreted in sweat.
Foetal calcium correlate with intake. The presence of phosphorous decreases calcium excretion.
REGULATION
The normal serum calcium is maintained by integrated actions of  Parathyroid Horome (PTH) and 
vitamin D metabolites, calcitonin, cytokines such as transforming growth factor B and interleukin 6 
(Am J Clin Nutr 2004;80;417 - 20) 
25 - Hydroxy cholecaliferol gets converted to active form 1, 25 dihydroxy cholecalciferol in proximal 
convuluted tubule in kidney where 1 α hydroxylase enzyme is present. 1, 25 dihydroxy cholecalciferol 
is a important hormone acts on gut and kidney to reabsorb calcium. Paratharmone is a major hormone, 
any fall in ionized calcium countered by secretion of paratharmone which acts on bone causing bone 
resorption, in the kidney it acts on the distal tubule causing calcium reabsorption and through 
stimulation of vitamin D3 which increases calcium absorption from intestine, reabsorpition from 
kidney and mobilization from bone. All these help to increase the calcium level and achieve an 
optimum level in serum. 1, 25 dihydroxy Vitamin D is reduced in pre-eclampsia because of placental 
hypoperfusion and renal damage (Serner et al 1981).
CALCIUM IN NORMAL PREGNANCY AND PRE-ECLAMPSIA
Because of substantiate foetal needs 300mg/ day and as well as increased renal calcium excretion from 
augmented glomerular filtration. The concentration of total calcium in maternal serum gradually 
declined during pregnancy reaching a nadir during the III trimester and rising slightly thereafter PTH 
levels were assumed to be increased in pregnant women, (However seeley and co-worker 1997 
reported a significant in intact PTH level during pregnancy) and lower biological activity of 
parathyroid hormone. At the same time they showed a two fold increase in serum concentrate of 1, 25 
dihydroxy Vitamin D, which is probably of placental and decidual origin. It enhances gastrointestinal 
absorption of calcium to meet the needs of pregnancy.
Loper et al had shown that women with pre-eclampsia have significant decrease in level of serum 
ionized calcium. Total serum calcium level decline parallel to decreased serum albumin concentration 
(Power and amaises 1999) Importantly however ionized calcium levels are unchanged in normal 
pregnant women (Dahlman and Colleagues 1994). But serum ionized calcium is lower in pre-
eclampsia, at the same time intracellular concentration of ionized calcium is greater in patients with 
pre-eclampsia (Pereyra et al, 1991) and decreased calcium dependant ATPase activity of erythrocytes 
and hypocalciuria.
HYPOCALCIURIA
The urinary calcium excretion in normal pregnancy is 350-620mg/day compared with 100-250mg/day in 
non pregnant women.
The pathophysiology of hypocalciuria in pre-eclampsia patient is not well understood. Reduced urinary 
calcium excretion may be the result of dietary, renal and hormonal factor. During pregnancy calcium 
transported from maternal blood across the placenta, therefore increased calcium uptake by placenta 
may result in maternal hypocalciuria.
In pre-eclampsia, there is reduction in calcium 1, 25 dihydroxy Vit.D which enhances the PTH, there is 
reduced placental perfusion with renal damage, this lead to decreased synthesis of active form of Vit. 
D, which would stimulate PTH and thereby increases distal renal tubular as well as proximal tubular 
level of reabsorption of calcium resulting in hypocalciuria. Vasoconstriction resulting from low 
calcium which causes decrease in glomerular filtration, increased tubular reabsorption of calcium and 
diminished urinary calcium excretion. Urinary calcium excretion is inversely related to the incidence of 
pre-eclampsia.
Rodriguez et al, have found 24 hour urinary calcium excretion was lower in preeclamptic patients than 
in the normotensive group in his recent studies and also he evolved the value of calcium/ creatinine 
ratio as predictive test using value of < 0.04µg/ml.
Weiss et al, study says that, in pre-eclampsia the fetus is exposed in utero to toxemic environment, its 
kidney function may be similarly affected. So there may be higher aminiotic fluid divalent cation 
concentration due to maternal hypocalciuria.
Many studies on the urinary calcium excretion have been performed.
Ye-Y; Dai.S, Gng-Xi et al., at Quindo Medical College, predictive value of urine calcium measurement 
on occurrence of Pregnancy induced hypertension gives a predictive value of urinary calcium/ 
creatinine ratio in 24 hour urine sample. The values were significantly lower than that of in normal 
pregnant group (P <0.01) 3mmol/ of urinary calcium concentration and 0.04 of calcium creatinine ratio 
with sensitivity of 76.2% and specificity of 97.5%. They conclude the lower urinary calcium excretion 
is valuable marker.
Taufield PA (1987): Pre-eclampsia is associated with hypocalciuria due to increased tubular 
reabsorption of calcium. He measured 24 urinary calcium excretion and found low total and fractional 
excretion in women with pre-eclampsia, when compared to normotensive women. The urinary calcium 
concentration < 12mg/dl in 24 hours collection has positive and negative predictive value of 85% & 
95% respectively for the diagnosis of pre-eclampsia.
Sanchez-Ramos.L (1991): determination of low - urinary calcium creatinine ratio in a single voided 
urine sample is accurate as a 24 hours collection. This phenomenon occurs early in pregnancy and 
persists throughout gestation and it is useful for the early identification of patient at risk.
Suzuki Y. Hayashi (1992): concludes that urine calcium / creatinine ratio was significantly lower in 
women with pre-eclampsia than in healthy pregnant women.
Ozcan T (1995): UCCR < 0.04 predicts development, of PE in later pregnancy. This study suggests 
that a single urinary calcium / creatinine ratio might be an effective marker for predicting pre-
eclampsia in a high risk population.
Saudan PJ & Shaw L (1998): in American Journal of Hypertension States: Gestation hypertensive 
patients who became preeclamptic had lower urinary calcium / creatinine ratio than women whom 
remained gestational Hypertension. This test had a sensitivity of 68% and specificity of 70%. This low 
value preceeds the emerging of pre-eclampsia by 12 days.
Kar et al (2002) of Goralehpur and Desai et al (2001) from Barod: Role of urinary calcium / creatinine 
ratio in first morning urine in the mid trimester of pregnancy for predicting risk of PIH. The ratio <0.04 
is predictive of increased risk of pre-eclampsia. A ratio of > 0.04 predicted a 96% chance of not 
developing pre-eclampsia.
Serum creatinine concentration varies with glomerular function of creatinine clearance. So even the 
small changes in glomerular function are best detected by creatinine clearance.
HYPERTENSION
Evidence supporting an inverse relationship between calcium intake and blood pressure has 
strengthened in the past decade, low calcium intake may cause high blood pressure by stimulating 
release of PTH and (or) renin thereby increasing intracellular calcium in the vascular smooth muscle 
causing vasoconstriction. Extra cellular ionized concentration is crucial for the production of 
nitricoxide and regulation of vascular sensitivity. Vasoconstriction causes decrease Glomerular 
filtration rate (GFR), increased tubular reabsorption of calcium and diminished calcium excretion. 
Calcium supplementation has been reported to reduce the incidence of pre-eclampsia (Repke & Villar 
1990).
Different studies have been performed to study the relationship between calcium, 
metabolism and hypertension 
Smolarczy K.R. et al: Patient with Pregnancy Induced Hypertension due to renal impairement there is 
reduction of urinary calcium excretion and calcium concentration in blood.
Prada JA et al: Pregnancy induced hypertension produced by low calcium diet lead to significant 
increase in maternal blood pressure vascular resistance.
The role of calcium to prevent Pre-eclampsia is as follows
I. High dose of calcium exert a negative feed back 
effect on parathyroid hormones 
↓
Lowering intracellular calcium ion levels 
↓
Smooth muscle relaxation and diminished 
responsiveness to pressor stimlus.
II. Further more calcium supplementation is associated with higher levels of calcium excretion 
which is coupled with an ion exchange with magnesium resulting in increased level of magnesium 
- smooth muscle relaxation in vessels → control of hypertension 
(Belzian et al 1998).
SCREENING TEST
Comparison of various other screening tests with urinary calcium / Creatinine ratio as 
a predictor of Pre-eclampsia.
A variety of biochemical and biophysical markers based primarily on rationales implicated in the 
pathology and pathophysiology of pre-eclampsia have been proposed for its prediction.
The good screening test should be sensitive, cheap, easy to perform, and readily interpretable with high 
predictive value.
Screening test can be divided into 3 categories.
I. Haemodynamic Tests
1. Angiotension II infusion test:  Talledo et al 1968
Abnormal vascular reactivity of patients destined to develop pre-eclampsia may be detected several 
weeks before the clinical signs and symptoms appears. Women requiring less than 8ng/kg/minute of 
Angiotension II to raise their diastolic BP by 20mmHg had a positive predictive value of 20-40% of 
developing pre-eclampsia (Friedman).
2. Isometric hand Grip Test
Dagani et al Increase in diastolic pressure of more than 20mmHg during a hand grip exercise test at 
28-32 weeks had positive predictive value of 20-30%. This test is not affected by positional change and 
is safe and easily performed, although it is time consuming taking upto 30minutes to perform. Since 
hand grip represent sympathetic nervous system activity. There is little evidence that pre-eclampsia is 
mediated by sympathetic activity. This requires further evaluation. False negative 4% & False positive 
19%.
3. Roll over test
Proposed by Gant et al, An increase > 20mmHg of diastolic blood pressure induced by having women 
assume the supine position after lying left lateral position done at 28 - 32 weeks was shown to be 
associated with later on occurrence of pre-eclampsia is 33%. Though the test is simple to perform and 
requires only time and personnel rather an elaborate equipment.
4. Mean arterial pressure - Page and Christianson
Suggested that patients with MAP of >90mmHg in II trimester should be regarded as a risk category 
but the predictive value varies greater from one study to another. The position of the arm relative to 
heart level also affect the recording. There is also variation of blood pressure with the circadian rhythm, 
values being highest during the afternoon and early evening. This method to be effective, increased 
uniformity of recording measurement is necessary.
5. Uterine artery Doppler Velocimetry
Doppler measurement of uterine artery impedance in the mid II trimester (18-24 weeks) is an early 
screening test (Bewley, 1991), Chappel based on the presumption that impaired trophoblastic invasion 
of spiral arteries causes decreased utero placental blood flow. The presence of a high systolic - diastolic 
ratio, persistence of diastolic notch may predict pre-eclampsia (Irion et al 1998) and Resistance Index > 
0.58. Positive predictive value was only 28% (Friedman and Lindheimer 1999). Studies concluded 
that the test was not helpful in the management of Individual patient.
URINARY ASSAYS
1. Urinary calcium excretion
Studies found that urine calcium excretion is reduced in 
pre-eclampsia. A study showed that urinary calcium excretion average of 
313+140mg in normal pregnancy and 248+134 in transient hypertension. Hypocalciuria is due to 
increased distal tubular reabsorption alternatively proximal tubular reabsorption. 24 hour urinary 
calcium excretion less than 12 mg/ dl had sensitivity of 88% and positive predictive value of 91%. 
(Sanchez - Romos, Obstet & Gynecol 1991).
Another study reported that patient with pre-eclampsia had significantly less excretion of total calcium 
(129.7 + 18.7mg/24 hours) than normotensive (283.9 + 12.3) or those with gestational hypertension 
(233.2 + 22.3) (P = 0.0001) using a receiver operator curve, urinary calcium threshold of 12mg/ dl was 
choosen as a predictor for the development of pre-eclampsia with sensitivity of 83% specificity of 91%, 
Positive predictive value 83, Negative predictive value 91.
2. Urinary calcium / Creatinine Ratio
A number of studies have shown that a low calcium and creatinine excretion is a valuable marker for 
pre-eclampsia prediction. Since creatinine clearance is not significantly different among normotensive 
and pre-eclampsia, (134.4 + 14.9) in Pre-eclampsia (141.9 + 7.2) and in gestational Hypertension, 
(150.2+6.5) in normotensive pregnant women. Studies were done using single voided urinary calcium / 
creatinine ratio in the prediction of pre-eclampsia and it correlated well with 24 hours calcium 
excretion. Hence 24 hours urinary calcium excretion can be estimated from single voided urine sample.
Sanchez - Ramos et al., indicate that this phenomenon occurs early and presents throughout gestation 
being potentialy useful for prediction of pre-eclampsia. 
Rodriquez et al., evaluated the value of calcium / creatinine ratio as predictor test using value of < 0.04 
µg/ml.
24 hours urinary calcium / creatinine ratio in pre-eclampsia were significantly lower than that of 
normotensive pregnant women (p<0.0001). 3 mmol/L of urinary calcium concentration, urinary 
calcium creatinine ratio 0.04µg/ml were chosen as predictive threshold for development of PIH with 
sensitivity of 76.2%, 81.0% and specificity of 97.5%, 98.2% respectively.
Indian study showed spot urinary calcium/ creatinine ratio done in pregnant women between 24-34 
weeks of gestation showed that 13.46% had urinary calcium creatinine ratio <0.04. Out of which 71.4% 
patients developed pre-eclampsia which was found to be statistically highly significant and 80% 
developed pre-eclampsia with history of risk factors.
3. Micro albuminuria
By Radio immuno assay can detect microalbuminuria of the value >11 µg/ml when done between 
24-34 weeks it indicates positive result.
4. Urine Kallikrein / Creatinine ratio
Kallikrein Creatinine ratio of <170 between 16 and 20weeks of pregnancy predicts future development 
of pre-eclampsia. Camphell et al., 1987: sensitivity of 83% false positive ratio of 50%, false negative 
ratio 10%, positive predictive value of 91%. 
5. Urinary metabolites of PGI2 - help in diagnosis of pre-eclampsia
6. Markers for endothelial dysfunction 
Fibronectin, a glycoprotein synthesized in the vascular endothelium elevated in pre-eclampsia - 2 fold 
increase in fibronectin, >400 µg/ml. Positive predictive value was only 39% negative predictive value 
98% (Chavarria et al, 2003) Sensitivity is quiet low only (69%) (Pallberg & Colleagues).
Plasminogen inhibitor 1 is increased relative to plasminogen activator (Caron and Colleagues 1991) 
Thrombomodulins, cell adhesion molecules and Endotheline I are also found to be increased.
7. Coagulation factors 
1) Increased Thromboxane A2 (Fitzgerald et al). 2) Increased Factor VIII. 3) Decreased Antithrombin 
III.  4) Thrombocytopaenia and abnormalities platelet function (Aggregation).
8. Cytokines
Increase IL and TNF α - not yet proved sufficiently (Savvidon and colleagues 2002, Benyo 2000).
9. Anti angiogenic factor
Levin RJ et al, soluble fms like Tyrosine Kinase I, Endoglin-Increased, Ratio of sFlt1: PIGF - more 
accurate (Devivo et al).
MARKERS OF OXIDATIVE STRESS
1. Malondialdehyde lipid peroxidation (Hubel & Co-authors 1989).
2. Pro oxidants (Herbert and Colleagues 1994)
3. Homocysteine (Cotter and Associates 2001) elevated level around mid pregnancy had a 
3-4 fold risk of development of pre-eclampsia.
4. Triglycerides, free fattyacids and lipoprotein (Hobel and Colleagues 1996).
5. Prostaglandin Isomerase; marker of impending pre-eclampsia (Regan and Fitz Gerald, 
1997).
These tests are not economical they are not popularized.
OTHER
1. Uric Acid
Elevated uric acid levels exceeding 5.9 mg/dl is considered significant correlation well with sensitivity 
and perinatal outcome.
2. Fibronectin 
Increased serum cellular fibronectin level in some women with pre-eclampsia (Magann EF et al).
3. Placental peptides
HCG (Ashoc R & colleagues 1997) inhibin A & inhibin B - in the search for early pregnancy marker 
for pre-eclampsia (Woodruff) 
4. Plasma P Selection: Plama P selectin as the earliest predictor in the first trimester is under 
study.
5. Urinary podocyte excretion: Highly sensitive and specific marker (Garovic et al).
6. Enzymes and Hormones:  Increased levels of plasma cystyl amino peptidase, Pappa-
A (Wood and Durham) and high level of β HCG (Noguera et al).
7. FOETAL DNA
Foetal DNA in maternal serum may be predictive of pre eclampsia.
PREVENTION OF PRE-ECLAMPSIA
Pregnancy is a process of physiologic adaptation which occur primarily is an effort to supply the 
developing fetus with their nutrients that are essential for its proper development and growth. 
Preventive measures have been concentrated to relieve vasospasm and to correct the disturbed 
prostaglandin synthesis which lead to platelet aggregation and endothelial damage. There are no 
definite preventive methods but attempt should be made for early detection of high risk patients.
Thomas Brewer rightly stated that pre-eclampsia is a complication of maternal malnutrition whose 
symptoms can be largely eliminated by eating a well balanced diet.
A study by the Dietary Approaches to stop Hypertension (Dash) demonstrated that dietary 
manipulation significantly lowers the Blood pressure.
Prevention can dealt with 
1. Non medical measures
2. Medical measures.
SALT RESTRICTION
This may be used as a means to prevent the onset of essential hypertension but not be used for 
gestational Hypertension and Pre-eclampsia.
BED REST
This may be useful in known hypertensive patients to reduce the severity.
FISH OIL
The benefit from fish oils seems to be associated with long chain  n-3 fatty acids, C-20, n3 
eicosepentoicacid and docosepentanoicacid & docosahexanoid acids. They decrease platelet 
aggregation on endothelial cells and leads a relative state of vasodilatation.
PLANT OIL
Linoleic and Evening primrose oil (3mg Linoleic + 32mg of Gammalinoleic acid / day.
CALCIUM
Proposed mechanism where by calcium supplementation may reduce blood pressure.
Reduced serum calcium 
↓ 
Increases Vit. D stimulation - interact with renin / angisotensin 
↓ 
(Through its link to PTH) Vit. D receptors present in the smooth muscle reduction of altered Vit. D 
metabolism smooth muscle proliferation 
↓ 
Development of atherosclerosis 
↓ 
Hypertension
High intake of calcium of 1.3g/d showed a reduced incidence of both Pre-eclampsia & Eclampsia 
(Villar, J American J Clin - Nutrition 1980). World Health Organization (2006) supplementation with 
calcium 1.5g/day significantly reduces the risk of maternal neonatal morbidity and preterm delivery in 
the later among young women.
Cochrane systematic review noted protective effects of calcium supplementation only in women with 
low calcium intake.
ANTIOXIDANT 
Antioxidant therapy significantly reduced endothelial cell activation in a study performed by (Chappell 
and associates, Lancet 1999). There was a significant reduction in the incidence of Pre-eclampsia in 
women who was given with vitamin C and E.
MEDICAL MEASURES
Low dose aspirin appears to be beneficial for women at high risk of pre-eclampsia (Cochrane Review - 
19% reduction in risk of pre-eclampsia).
AIM OF THE STUDY
To determine whether a low urinary calcium / creatinine ratio                 (< 0.04) in a spot urine sample, 
obtained in asymptomatic pregnant women between 24-34 weeks of gestation can predict the 
subsequent development of pre-eclampsia.
MATERIALS AND METHODS
This study was conducted at department of Obstetrics and Gynaecology, Govt. R.S.R.M.Lying in 
Hospital attached to Stanley Medical College, Royapuram, Chennai.
STUDY PERIOD: The Period of Study was from July 2008 – September 2009
STUDY DESIGN: PROSPECTIVE STUDY
150 Pregnant women were attending the antenatal clinic at R.S.R.M. Lying in Hospital, were registered in this 
study. Only those pregnant women whom we could follow to term and were planning delivery at R.S.R.M. 
Lying in Hospital, Royapuram Chennai, were included in this study.
150 normal pregnant women between 24 to 34 weeks of gestation were divided into two groups (1) 
study group comprised of 100 pregnant women with nulliparity (majority) as high risk factor for 
development of pre-eclampsia who were normotensive at registration with blood pressure <140/90 
mmHg and no proteinuria on dipstick (2) control groups comprised of 50 normal multiparous women. 
With no risk factor what so ever for the development of pre-eclampsia were included.
PATIENTS SELECTION CRITERIA
Inclusion Criteria 
1. Gestational age between 24-34 weeks.
2. Women who intented to have their deliveries at RSRM lying in hospital.
Exclusion Criteria 
1. History chronic hypertension
2. History of Diabetes Mellitus
3. History of Renal disease
4. Blood pressure > 140/90 mm Hg
5. Evidence of proteinuria by the dipstick method.
The study was done on asymptomatic primi, and pregnant women with Rh Negative, with previous h/o 
pre-eclampsia, family h/o 
pre-eclampsia were also included.
2nd and 3rd gravida with no risk factors for development of 
pre-eclampsia, were included in control group.
METHODOLOGY
In all the pregnant women included in the study, a written informed consent was obtained.
1. No dietary alterations were recommended
2. Detailed history was taken.
3. Complete examination
i. General examination
ii. Clinical examination
– Cardiovascular system
– Respiratory system
– Central nervous system
iii. Obstetric examination was done.
4. Blood Pressure
i. In sitting posture
ii. Phase Korotkoff V sound was taken to determine the diastolic component
5. Basic Investigations 
i. Haemoglobin
ii. Blood Grouping and Rh Typing
iii. Urine – Albumin 
– Sugar
– Deposits
6. Single voided urine sample in the morning was collected from all the patients in calcium 
free vial and about 5ml of non-heparinized blood was collected at the same time.
Both the urine and blood sample were sent to the Biochemistry Laboratory of 
Stanley Medical College hospital without delay.
7. Serum and urinary calcium estimation wad done using commercially available kits 
using, Ortho-cresolphthalein Complexone Method (OCPC) on a semi auto analyser.
8. Serum and urinary creatinine estimation was done by MODIFIED JAFFE’S METHOD 
on a semi auto analyser.
9. Followed up with routine antenatal visits for signs and symptoms of pre-eclampsia by 
routine examination of blood pressure, serial weight, edema, and investigation of pre-
eclampsia when required and results were tabulated.
10. Mode of delivery and fetal outcome was noted 

METHODS
Ortho-cresolphthalein complexone Method of estimation of Calcium.
PRINCIPLE 
Calcium in alkaline medium combines with the O-cresolphthalein complexone to forms a purple 
coloured complex. Intensity of colour formed is directly proportional to the calcium concentration in the 
sample.
Ortho- cresolphthalein complexone reacts with calcium at pH 10.0 to form a purple coloured complex. 
Calcium + OCPC  purple colour complex.
PROCEDURE:
500µl of reagent mixed with 10µl of samples incubated for 5 minutes at room temperature (25-30oC). 
Absorbance of standard and sample is read against reagent blank at 578 nm with yellow filter with in 
30 minutes.
TEST RESULTS
Absorbance of test
Calcium concentration in mg/dl = -------------------------------- x 10
Absorbance of Standard
CREATININE ESTIMATION BY MODIFIED JAFFE’S METHOD
Creatinine is the carbolic product of creatinine phosphate and it is excreted entirely by the kidneys.
Creatinine reacts with picric acid, in alkaline medium to give orange coloured complex – creatinine 
Picrate (Jaffe’s reaction). Intensity of colour formed during the fixed time is directly proportional to the 
amount of creatinine present in the sample.
Creatinine + Alkaline picrate  Orange coloured complex
Procedure:
Serum Creatinine
500µl of reagent and 50µl of sample added and mixed well and immediately reading was taken by 
using semi autoanalyser and estimate the colour at 520nm green filter.
Urinary Creatinine
500µl of reagent and 50µl of urine sample added after diluted in distilled water in one in 10 dilution 
mixed well and estimate the colour at 520nm using green filter. The urinary creatinine results was 
multiplied by 10. 
RESULTS
TABLE – I: 
DISTRIBUTION OF PERSONS IN STUDY AND CONTROL GROUP ACCORDING 
TO AGE
Age in 
years
Study group Control
Number % Number %
Total
17-22 64 64% 15 30% 52.7%
23-28 30 30% 26 52% 37.3%
29-34 6 6% 7 14% 8.7%
35-39 – – 2 4% 1.3%
Total 100 100% 50% 100% 100%
Above table, shows the distribution of persons in study and control group according to age 52.7% in 
age group of 17-22, 37.3% in age group of    23-28, 8.7% in age group of 29-34 and 1.3% in age group 
35-39%.
TABLE – II: 
DISTRIBUTION OF PATIENTS WITH PRE-ECLAMPSIA ACCORDING TO AGE
Age in 
years
Study group Control group
Total No. Pre eclampsia positive Total No. PE positive
17-22 64 11 15 -
23-28 30 1 26 -
29-34 6 2 7 2
35-39 - - 2 -
Total 100 14 50 2
According to MacGillivary (1958) the relationship of maternal age and incidence of pre-eclampsia 
gives a “J” shaped curve with high incidence among young primi gravida and markedly increased 
incidence among older primigravida. In study group preedampsia was high between 17-22 years and 
pre-eclampsia was high above 30 years.
TABLE – III: 
DISTRIBUTION OF PATIENTS WITH PRE-ECLAMPSIA ACCORDING TO PARITY
PARITY TOTAL PRE-ECLAMPSIA POSITIVE %
Nulliparous 94 12 (12.77%) 75%
Multiparous 56 4 (7.14%) 25%
Above table shows the distribution of patients with pre-eclampsia according to parity. Pre eclampsia is 
more common in nulliparous women. This table show high incidence of pre-eclampsia in nulliparous 
(75%) than in multiparous women, P value < 0.001 which is highly significant.
TABLE – IV: 
INCIDENCE OF PRE-ECLAMPSIA IN RELATION 
TO PARITY IN STUDY & CONTROL GROUP
PARITY
STUDY GROUP CONTROL GROUP
Tota
l No.
Develope
d PE
Not 
Develope
d
PE
Incidence
incidenc
e
Over all 
incidenc
e
Tota
l No.
Devel
o ped 
PE
Not 
Develope
d
PE
Incidence
inci 
denc
e
Over all 
incidence
NULLI 
PAROU
S
94 12 (85.71%)
82 
(95.35%) 12.76%
MULTI 
PAROU
S
6 2 (14.29%) 4 (4.65) 33.33%
14%
- - - -
50 2 (4%) 48 (96%) 4%
4%
The above table shows development of pre-eclampsia in relation to parity both in study group & 
control group. In study group the incidence was high (14) when compared to control group 4%.
TABLE – V: 
RELATIONSHIP OF URINARY CALCIUM/ CREATININE RATIO AND 
DEVELOPMENT OF PRE-ECLAMPSIA
GROUP
DEVELOPED 
PRE-ECLAMPSIA
NOT DEVELOPED 
PRE-ECLAMPSIA
NO % NO %
TOTAL
UCCR < 0.04 n 
= 16 13 81.25% 3 18.75% 16
UCCR > 0.04  n 
= 134 3 2.23% 131 97.76%
134
Total 16 134 150
This table shows the relationship of urinary calcium / creatinine ratio and development of pre-
eclampsia in both study and control group. 
16 patients showed urinary calcium creatinine ratio < 0.04 134 patients shows UCCR > 0.04. 81.25% 
of persons with UCCR < 0.04 and develop pre-eclampsia. 97.76% of persons with calcium / creatinine 
ratio > 0.04 doesn’t develop pre-eclampsia P value <0.001 which is highly significant.
TABLE – VI: 
RELATIONSHIP OF UCCR AND DEVELOPMENT OF 
PRE-ECLAMPSIA IN STUDY GROUP
Appearance of PE
UCCR < 0.04 (N=14) UCCR > 0.04 (N=86)
No % No %
Positive for PE 12 85.71% 2 2.33%
Negative for PE 2 14.29% 84 97.67%
This table shows development of pre-eclampsia in study group in relation to the cut off value of UCCR 
<0.04. Out of 100 patients 14 patients showed UCCR <0.04. Out of 14 patients 12 (85.71%) patients 
developed PE. 2 (14.9%) patients didn’t develop pre-eclampsia with UCCR < 0.04. The remaining 86 
patients showed a UCCR value of 
> 0.04, in this group 2 patients developed pre-eclampsia (2.33%) 84 patients didn’t develop pre-
eclampsia (97.67%).
TABLE – VII: 
RELATIONSHIP OF URINARY CALCIUM & CREATININE RATIO AND 
DEVELOPMENT OF PRE-ECLAMPSIA IN CONTROL GROUP
APPEARANCE OF 
PRE-ECLAMPSIA
UCCR < 0.04 
n=2
UCCR > 0.04 
n=48
NO. % No %
Developed PE 1 50% 1 2.08%
Did not develop PE 1 50% 47 97.92%
Above table shows relationship of UCCR & development of pre-eclampsia in control group. 50% of 
person with UCCR < 0.04 developed pre-eclampsia and 50% didn’t develop pre-eclampsia even with 
UCCR < 0.04. The remaining 48 pregnant women showed UCCR value of > 0.04, in this group one 
patient developed pre-eclampsia (2.08%),  47 patients did not develop pre-eclampsia (97.92%).
TABLE – VIII: 
RELATIONSHIP OF SERUM CALCIUM (mg/dl) 
AND PRE-ECLAMPSIA
Serum 
Calcium (mg/dl)
Pre-eclampsia
Developed Not developed
Total
<=7.5 14 (87.5%) 15(11.2%) 29 (19.3%)
7.6-8.5 2(12.5%) 72(53.7%) 74 (49.3%)
8.6-9.5 - 27(20.1%) 27 (18.0%)
9.6-10.5 - 13(9.7%) 13 (8.7%)
>10.5 - 7(5.2%) 7 (4.7%)
Total 16 134 150 (100%)
The above table shows 87.5% of those who developed pre-eclampsia had serum calcium level below 
7.5 mg/dl and 12.5% who developed pre-eclampsia between 7.6 –8.5 mg/dl.
Chi square test P value <0.001 which is highly significant.
TABLE – IX: 
DISTRIBUTION OF PATIENTS WITH PRE-ECLAMPSIA ACCORDING TO SERUM 
CREATININE
SERUM CREATININE 
mg /dl
PRE-ECLAMPSIA
DEVELOPED NOT DEVELOPED
Total
0.6 – 0.7 - 89(66.4%) 89
0.8-0.9 10 (62.5%) 41 (30.6%) 51
1.0-1.2 6 (37.5%) 3 (2.2%) 9
>1.2 - 1 (0.74%) 1
Total 16 134 150 (100%)
This table shows development of pre-eclampsia in relation to serum creatinine. 62.5% patient 
developed pre-eclampsia in the range of 0.8 – 0.9% and 37.5% in range of 1.0 –1.2 mg/dl.
TABLE – X: 
DISTRIBUTION OF PATIENT ACCORDING TO THEIR FIRST APPEARANCE OF 
PRE ECLAMPSIA IN WEEKS
Gestational age in weeks Number of Patients
26-28 -
29-31 -
32-34 2
35-37 5
38-40 9
>40 -
The above table shows most patients developed pre-eclampsia between gestational age of 36 to 40 
weeks indicating  that the incidence is higher in later part of gestation.
TABLE – XI: 
DISTRIBUTION OF PATIENTS ACCORDING TO SEVERITY OF PRE-ECLAMPSIA 
IN STUDY AND CONTROL GROUP
Type of 
pre-eclampsia Study group Control group
Mild Pre-eclampsia 13 2
Severe Pre-eclampsia 1 -
14 2
The above table denotes that distribution of persons in study and control group according to severity of 
pre-eclampsia. 13 patients in the study group and two patients in the control group had mild pre-
eclampsia and one patient in the study group had severe pre-eclampsia.
TABLE – XII: 
PREDICTIVE VALUE OF URINARY CALCIUM / CREATININE RATIO AS A 
SCREENING TEST FOR PRE-ECLAMPSIA
Screening Test
UCCR <0.04 Developed pre-eclampsia Not Developed pre-eclampsia
Positive
16 13 (81.25%) 3 (18.75%)
Negative
134 3 (2.23%) 131 (97.76%)
13 out of 16 patients who developed pre-eclampsia had UCCR < 0.04
Using Chi square tests
P value <0.001 which is highly significant.
This screening test has 
– Sensitivity of 81%
– Specificity of 98%
– Positive predictive value of 81%
– Negative predictive value of 98%
DISCUSSION
Though by definition, pre-eclampsia can occur at any time after 
20 weeks of gestation it usually develops at the end of pregnancy, during labour (or) in immediate post 
partum period.
Renal function changes in pre-eclampsia have been documented and several prospective studies 
indicate that atleast some of these changes are present before the diagnosis of pre-eclampsia.
The present study was conducted on asymptomatic pregnant women between 24-34 weeks of gestation. 
All the women included in the study were normotensive with a blood pressure <140/90 mmHg, did not 
have pedal odema, and no proteinuria by dipstick method. In study group majority (96%) of the 
patients were nulliparous. Nulliparity as a risk factor was chosen because of very high incidence of pre 
eclampsia in nulliparity. 15 times greater risk compare to multiparity. In control group exclusion 
criteria was used and patients were picked up. 
The morning urine sample was collected in calcium free vials and anlaysed for calcium and creatinine 
levels. Spot urine calcium and creatinine ratio was taken in this study because it correlated well with 24 
hours calcium excretion. At the same time serum calcium and creatinine level were also estimated to 
see if there was any correlation.
In this study 150 patients were registered and 50 in the control group. Out of 150 patients 16 developed 
pre-eclampsia with incidence of 10.66% who was diagnosed with high blood pressure and proteinuria 
with (or) with out odema.
INCIDENCE
Mudaliar & Menon 10%
Sanchez Ramos 14%
Ritu Kamara et al 13.6%
Rodriguesz et al 10.6%
Present study 10.7%
Present study shows 10.7% incidence of pre-eclampsia which is similar to Rodriguez et al and 
Mudaliar Menon study.
AGE INCIDENCE
Women of different age group were included in the study and control group. 68.75% of those who 
developed pre-eclampsia were in the age group of between 17-22 years. This is accordance with 
MACGILLVIRAY’S report on age incidence of Pre-eclampsia which states that the incidence of pre-
eclampsia is high among young primigravida. 12.5% of those who developed pre-eclampsia were in the 
age group more than 30 yrs. 
Observation showed that the extremes of age group has prediliction for pre-eclampsia.
In control group comprising of multiparous women, in this group, pre-eclampsia developed in later age 
group because they might have an latent underlying hypertension.
PARITY
The incidence of pre-eclampsia is high in nulliparous that is 75% when compare to multiparous women 
(25%)
Those who developed pre-eclampsia in study group among nulliparity 12.76% and multiparity in both in 
study and control group was 7.14%
The over all incidence of pre-eclampsia in this study 10.66%. The over all incidence of pre-eclampsia in 
nulliparous women in this study 8%.
The incidence of pre-eclampsia in primigravida quoted in different studies.
Long & Oats 14.1%
Norwitz et al., 11.9%
Williams 7.6%
Present study 8%
Our study showed results similar to the study by Williams.
The overall incidence of pre-eclampsia in multiparity 2.6%. he incidence of pre-eclampsia in 
multigravida quoted in different studies.
Study %
Norwitz et al., 4.6%
Long & Oats 5.7%
Study by Campell 0.8 – 2.6%
Present study 2.6%
Our study similar to Campell study.
Since most of the patients in RSRM –lying in hospital belonging only to low socio-economic status. So 
comparison could not be done between different socio economic groups in this study.
The value of urinary calcium and creatinine ratio <0.04 taken as the cut-off value for prediction of pre-
eclampsia.
16 pregnant women out of 150 pregnant women had UCCR <0.04. Out of which 13 developed pre-
eclampsia (81.25%) and remaining 3 did not develop pre-eclampsia (18.75%). Sensitivity being 81%, 
specificity being 98%, the positive predictive value of 81%, and the  Negative predictive value of 98% 
and p value = <0.001 highly significant (using pearson chisquare table)
Analysis of results shows 81.25% of patients with UCCR <0.04 developed pre-eclampsia subsequently. 
18.75% of patients with 
UCCR <0.04 did not develop pre-eclampsia. Only 2.23% of patients with UCCR >0.04 developed pre-
eclampsia subsequently, 97.76% of pregnant women with UCCR >0.04 did not develop pre-eclampsia 
subsequently.
Among study group 14 patients had UCCR <0.04 out of which 12 patients developed pre-eclampsia 
with an incidence of 85.71% and 2 out of 14 who had UCCR <0.04 did not develop pre-eclampsia with 
an incidence of 14.29%.  86 (86%) pregnant women showed UCCR >0.04 out of which 2 patients 
developed pre-eclampsia (2.33%) and 97.67% did not develop pre-eclampsia sensitivity being 85%, 
specificity 97% postive predictive value 85.7% and negative predictive value of 97.6% p<0.001 (chi 
square chart).
In control group, 2 patients had UCCR < 0.04 out of which one patient developed with an incidence of 
50% and 1 out of 2 with UCCR<0.04, did not develop PE (50%). 48 pregnant women (96%) had 
UCCR>0.04 out of which one patient developed pre-eclampsia (2.08%) and where as 97.92% with 
UCCR >0.04 did not develop pre-eclampsia.
The mean urinary calcium in those who developed pre-eclampsia was 6.50 mg/dl. When it compared to 
16.1mg/dl who did not develop pre-eclampsia. The difference was statistically significant (<0.001). 
This is an accordance with the hypocalciuria observed in pre-eclampsia by various workers Taufield, 
Huikeshoven, Zwidershovdt & Suarez 1990.
The mean serum calcium was 6.9 mg/dl in patient with who developed pre-eclampsia when compared 
to 8.5mg/dl in pre-eclampsia negative group.  P value < 0.001 which is highly significant.
In our study those who developed pre-eclampsia (87.5%) had serum calcium level below 7.5mg/dl and 
12.5% had values between 
7.6-8.5mg/dl and 12.5% had values between 7.6-8.5 mg/dl. None of the patients with greater serum 
calcium values developed pre-eclampsia. Calcium deficiency has been implicated as a predisposing 
factor for the development of pre-eclampsia- BELIZAN, SANCHEZ, RAMOS 1991. Calcium 
supplementation reduces the occurrence of pre-eclampsia.
The mean serum creatinine in those who developed pre-eclampsia was 0.96 mg/dl while it was 0.71 
mg/dl in those who did not develop pre-eclampsia. Our study shows those who developed pre-
eclampsia (62.5%) had serum creatinine value between 0.8-0.9mg/dl and 37.5% shows the value 
between 1-1.2 mg/dl.
When family history of pre-eclampsia was taken into account 
2 cases was having family history of pre-eclampsia only one case showed UCCR <0.04 and that patient 
developed pre-eclampsia (100%).
One only patient had history of  pre-eclampsia in previous pregnancy and the same patient had UCCR 
<0.04 and developed pre-eclampsia at gestational age of 36 weeks (100%).
The following table shows the percentage of patients with UCCR <0.04 by different authors in their 
study.
Rodriguez et al., UCCR <0.04 83.0%
Suzuki et al., 1992 UCCR <0.04 58.0%
Kamra et al., 1997 UCCR <0.04 71.4%
Present study UCCR <0.04 81.5%
Our study is similar to Rodriguez et al., study.
2 patients in the study group and one patient (2.08%) in the control group with UCCR >0.04 developed 
pre-eclampsia.
From this study it has been found that most of the persons with the UCCR < 0.04 developed pre-
eclampsia between gestational age of 36-40 weeks indicating that the incidence is higher in later part of 
gestation.
This study shows that low UCCR in nulliparous is a very strong risk factor in development of pre-
eclampsia in late pregnancy.
Comparison of predictive value of UCCR in present study with other studies
Author Year
No of 
patient
s
Parit
y
Sensitivit
y in %
Specificit
y in %
PPV 
in %
NPV 
in %
Rodriguez et al 198
8
88 >0 70 95 64 96
Sanches Ramos 
et al
199
1
99 0 88 84 32 99
Ozcan et al 199
5
56 0 63 96 71 93
Ritu Kamra 
et al
199
7
104 >0 71.4 95.38 64.2
3
96.51
Kar Srivastava 199
9
100 >0 75 94.38 64.2
3
96.51
Present Study 200
9
150 >0 81 98 81 98
COMPARISON OF OUR STUDY WITH OTHER STUDY
In our study with low UCCR (<0.04) 81.25% developed pre-eclampsia which is similar to Rodrigruez 
et al.
Karsrivastava study shows negative predictive value of 96.5% our study showed negative predictive 
value of 98%.
Positive predictive value was highest in our study (81%) and in the Ozcan et al study shows 71%.
Maximum specificity was shown by Ozcan et al., 1995 of 96% and our study noted with 98% of 
values.
Sanchez Ramos et al., in his study of 99 patients shows a very high sensitivity of 88% and our study 
shows 81%.  As per Sanchez Ramos et al., study (Obstet gynecol 1991 April 77 (4): 510-3) sensitivity 
of 85% specificity of 91% and positive predictive value and negative predictive value of 85%, 91% 
respectively. Our study well correlated with Sanchez Ramos et al., study.
Izumi & Minakami (1997) measured calcium and creatinine concentration in spot urine samples at 12 
weeks (or) less of gestation. But they concluded that determination of calcium / creatinine ratio in spot 
urine sample in the 1st trimester is of only limited clinical value for identifying the patients with an 
increased risk for pre-eclampsia
Thus determination of UCCR in spot urine sample is valuable in predicting subseqeunt development of 
pre-eclampsia when a value of <0.04 is taken as cut off. (Kazerooni et al 2003 (< 0.03).
On statistical analysis, it was found that when UCCR is taken as a predictor of pre-eclampsia it was 
highly significant.
By using chi square test p value of <0.001 was arrived at which is highly significant.
The OCPC method of estimation of urinary calcium and modified Jaffe’s method of creatinine 
measurement is more accurate due to consistent way of estimation. Hence the results are accurate 
proving the worth of the test.
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SUMMARY
The results of analysis of the study is summed up as follows:
1. Pre-eclampsia developed in 10.66% of tested patients population between 36-40 weeks 
of gestation mostly. Patients developed pre-eclampsia in the form of raised blood 
pressure, proteinuria and with or without odema.
2. Nulliparity was found to be a significant high risk factor.
3. Family history of pre-eclampsia and previous history pre-eclampsia also a high risk 
factor for development of pre-eclampsia in 2 cases.
4. Urinary Calcium Creatinine ratio was < 0.04 in 10.66% patient out of which 81.25% 
that is 13 patients developed pre-eclampsia which was found to be statistically highly 
significant with the p value of <0.001.
5. Serum calcium level also found to be low in patients who developed pre-eclampsia and 
serum creatinine level also found to be higher.
6. Sensitivity 81%, specificity 98% Positive predictive value 81% Negative predictive 
value of 98%  P= <0.001 which is highly significant.
CONCLUSION
The study shows that spot urinary calcium creatinine ratio with the cut off value of < 0.04 done 
between 24-34 weeks of gestation is an excellent screening tool for the prediction of pre-eclampsia 
among numerous screening test with specificity of 98% and sensitivity of 81%, and  positive predictive 
value 81%, and negative predictive value 98%.
A young nullipara along with low UCCR is especially at a high risk for development of pre-eclampsia.
This test is ideal because
• Simple and easy to perform
• In expensive
• Non invasive and convenient for the patient 
Low UCCR value helps in identify the population who is at greatest risk to be included in 
primary preventation program.
Hence in routine antenatal care with screening test like urinary calcium Creatinine ratio in spot urine 
sample with the cut off value of <0.04 can be applied as a screening test for all women then this 
dreadful multisystemic condition can be treated in time.
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 Semi Auto Analyser and calcium and creatinine kit used for the study
MASTER CHART 
STUDY GROUP
S.
No.
Name Age Obstetric 
Code
IP No. Socio 
Economic
Status
High
Risk
factors
Serum Urinary
CalciumCreatinine Calcium Creatinine
UCCR
1. Malathi 20 Primi 7132 V 7.4 0.6 10.5 162 0.064
2. Kasthuri 22 Primi 7240 IV 8.0 0.7 15.2 185 0.082
3. Devi 20 Primi 7237 V 8.4 0.8 14.5 191 0.075
4 Kalpana 19 Primi 7254 IV 6.9 0.7 10.9 172 0.063
5 Dhana 
Lakshmi 
17 Primi 7224 V 7.3 0.9 12.4 182 0.068
6 Lakshmi 20 Primi 7209 V 10.4 0.9 16 175 0.091
7 Anjali 22 Primi 7245 IV 7.5 1.0 4.5 145 0.031 Developed Pre-
eclampsia 
8 Jaqulin 22 Primi 7233 IV 8.2 1 13.9 234 0.059
9 Thenmozhi 19 Primi 7241 V 8 0.6 16.7 197 0.084
10 Amulu 18 Primi 2176 IV 8 0.6 14.2 145 0.097
11 Vasanthi 17 Primi 10421 V 8.4 0.9 14.9 216 0.068
12 Tamilarasi 27 Primi 7202 V 7.7 0.7 13.9 200 0.069
13 Mary 21 Primi 7261 IV 10.3 0.8 19.0 191 0.099
14 Kathaleeswari 17 Primi 9787 V 9.8 0.6 17.1 199 0.085
15 Priya 19 Primi 9532 IV 10.9 0.7 20.1 174 0.115
16 Umamaheswari 22 Primi 7096 V 8.2 0.7 16.1 245 0.057
